Jaguar Health, Inc. (NASDAQ:JAGX) | WebDisclosure

Basculer en Français

10830	Companies
235020	Keywords
163903	Articles
125811	Press releases

Home
Companies
Jaguar Health, Inc.

PRESS RELEASE

published on 09/10/2024 at 16:00, 1 year 11 months ago

Jaguar Health Appoints Industry Veteran to Head Sales for Company’s Commercialized Oncology and HIV Products Including October 2024 Launch of Gelclair for Cancer Supportive Care
Jaguar Health, Inc. appoints Susan Krizancic as National Sales Director for Napo Pharmaceuticals, preparing for FDA-approved Gelclair® oral mucositis product launch in October 2024

Jaguar Health FDA-approved Gelclair Susan Krizancic National Sales Director
BRIEF

published on 09/06/2024 at 16:05, 1 year 11 months ago

Jaguar Health to Present at the September 9-11 H.C. Wainwright Annual Global Investment Conference

Pharmaceuticals Virtual Presentation Jaguar Health Lisa Conte H.C. Wainwright Conference
BRIEF

published on 09/06/2024 at 16:05, 1 year 11 months ago

Jaguar Health fera une présentation à la conférence annuelle sur les investissements mondiaux organisée par HC Wainwright du 9 au 11 septembre

Lisa Conte Médicaments Santé Jaguar Présentation Virtuelle Conférence HC Wainwright
PRESS RELEASE

published on 09/06/2024 at 16:00, 1 year 11 months ago

Jaguar Health to Present at the September 9-11 H.C. Wainwright Annual Global Investment Conference
Jaguar Health, Inc. (NASDAQ:JAGX) founder Lisa Conte to present virtually at H.C. Wainwright Global Investment Conference. Focus on plant-derived medicines for gastrointestinal distress

Gastrointestinal Distress Jaguar Health Lisa Conte H.C. Wainwright Plant-derived Medicines
BRIEF

published on 09/05/2024 at 14:35, 1 year 11 months ago

Jaguar Health Celebrates National Service Dog Month Highlighting Its Cancer Care Drugs

Cancer Care FDA Approval Jaguar Health Canalevia-CA1 Service Dogs
BRIEF

published on 09/05/2024 at 14:35, 1 year 11 months ago

Jaguar Health célèbre le mois national des chiens d'assistance en mettant en avant ses médicaments contre le cancer

Canalevia-CA1 Soins Contre Le Cancer Approbation De La FDA Santé Jaguar Chiens D'assistance
PRESS RELEASE

published on 09/05/2024 at 14:30, 1 year 11 months ago

Jaguar Health Celebrates National Service Dog Month: With its Supportive Cancer Care Drugs, Jaguar is Dedicated to the Health and Wellbeing of People and Dogs
Jaguar Health's Canalevia-CA1 drug receives FDA conditional approval for chemotherapy-induced diarrhea treatment in dogs, making it the first approved treatment for this condition

FDA Approval Jaguar Health Canalevia-CA1 Chemotherapy-induced Diarrhea Dogs
BRIEF

published on 09/04/2024 at 16:05, 1 year 11 months ago

Jaguar Health Announces Key Commercial and Development Milestones

Crofelemer Clinical Trials Jaguar Health Rare Diseases Gelclair®
BRIEF

published on 09/04/2024 at 16:05, 1 year 11 months ago

Jaguar Health annonce des étapes clés en matière de développement et de commercialisation

Crofelemer Essais Cliniques Maladies Rares Santé Jaguar Gelclair®
PRESS RELEASE

published on 09/04/2024 at 16:00, 1 year 11 months ago

New Innovators with Jane King Interview with Jaguar Health CEO Lisa Conte Spotlights Company’s Near-Term Commercial & Development Milestones
Jaguar Health, Inc. announces near-term activities including Gelclair launch and crofelemer trials for rare diseases. Includes Lisa Conte interview details

Jaguar Health Inc. Rare Diseases Gelclair Launch Crofelemer Trials Lisa Conte Interview

Accesswire

Published on 08/13/2026 at 12:00, 30 minutes ago

Zomedica Announces Strategic Collaboration with Boehringer Ingelheim Animal Health Canada Inc. to Expand Equine Endocrine Diagnostic Testing Using TRUFORMA(R) Platform
Published on 08/13/2026 at 09:05, 3 hours 25 minutes ago

Battery X Metals Appoints Lithium-Ion Battery and Electric Vehicle Entrepreneur William Fan as President to Advance Development of Its Patent-Pending Lithium-Ion Battery Rebalancing Technology Platform and Corporate Growth Initiatives
Published on 08/13/2026 at 08:00, 4 hours 30 minutes ago

Battery X Metals Maintains Y Lithium Project Claims in Good Standing and Evaluates Phase I Exploration Program
Published on 08/13/2026 at 07:30, 5 hours ago

Battery X Metals Announces Closing of Second Tranche of Private Placement to Advance Corporate Growth Initiatives
Published on 08/13/2026 at 00:30, 12 hours ago

Aton Closes CAD$4 Million Private Placement

View all ACCESSWIRE

EQS Group

Published on 08/13/2026 at 11:54, 35 minutes ago

25 Years Redcare Pharmacy: From a digital pioneer to Europe’s leading online pharmacy.
Published on 08/13/2026 at 11:52, 37 minutes ago

Holding(s) in Company
Published on 08/13/2026 at 11:49, 40 minutes ago

Form 8 - Genel Energy PLC: PUBLIC OPENING POSITION DISCLOSURE BY A PARTY TO AN OFFER
Published on 08/13/2026 at 11:10, 1 hour 20 minutes ago

Omio expands global ground transport network with Greyhound Australia partnership
Published on 08/13/2026 at 11:05, 1 hour 25 minutes ago

BIRKENSTOCK REPORTS FISCAL THIRD QUARTER 2026 RESULTS WITH 15% CONSTANT F/X REVENUE GROWTH LED BY DTC; RAISES GUIDANCE FOR FY26

Les Echos

Published on 08/11/2026 at 17:45, 1 day 18 hours ago

DAMARTEX / Droits de vote bruts et réels au 31 juillet 2026
Published on 08/11/2026 at 17:40, 1 day 18 hours ago

Infotel : Déclaration des transactions sur actions propres réalisées du 3 au 7 août 2026 dans le cadre du programme de rachat d’actions
Published on 08/10/2026 at 18:00, 2 days 18 hours ago

AXA: Information relating to the number of voting rights and shares making up the share capital on 31/07/2026
Published on 08/10/2026 at 18:00, 2 days 18 hours ago

AXA : Information relative au nombre total de droits de vote et d'actions composant le capital social au 31/07/2026
Published on 08/10/2026 at 17:45, 2 days 18 hours ago

Weekly share buyback

View all LES ECHOS COMFI WIRE